Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06201728 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Asthma Flare-up Clinic After Exacerbation

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Primary completion date changed from estimate of Sep 1, 2026 to Jun 18, 2026
    • Study completion date: Sep 1, 2026 to Dec 31, 2026
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Secondary endpoints: details revised at 12 of 19 entries
    • Study description revised
    v4
  4. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Mar 1, 2024 to May 1, 2024
    • Site contact updated
    v3
  5. Secondary endpoints: 14 to 19
    • Study description expanded, about 2 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this interventional study is to examine the effect of asthma flare-up clinic follow-up in adult subjects after an asthma flare-up. This study aim to answer the following questions: 1. Does a follow-up in a flare-up clinic improves disease outcomes? 2. Does a follow-up in a flare-up clinic improves disease management? Participants in the intervention group will take part in a structured follow-up at the asthma flare-up clinic at three time points. Each visit will include questionnaires, pulmonologist examination and consultation, laboratory tests and spirometry. The control group will undergo phone-call follow-up with a research coordinator in similar time frames as the intervention. Researchers will compare the two groups to see if the clinic follow-up affects the study outcomes.
Trial Details
NCT Number NCT06201728
Lead Sponsor Tel-Aviv Sourasky Medical Center
Collaborators: AstraZeneca
Conditions
(from sponsor)		 Asthma, Asthma Attack
Related terms Asthma
Enrollment 230 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov